Companies go long by investing in longevity

Investments in research and treatments aimed at creating an ostensible fountain of youth are booming

May 17, 2015 @ 12:01 am

By Liz Skinner

A dizzying number of research institutes, wealthy entrepreneurs and companies, including Google Inc., are investing in research and treatments aimed at creating an ostensible fountain of youth.

Google and Arthur Levinson, Genentech's former chief executive, created a private research and development company two years ago called Calico. The biotech is focused on aging research and therapeutics, and it is partnering with pharmaceutical firm AbbVie to develop and market drugs for the diseases most associated with aging.

Most recently Calico said it is pairing with the Buck Institute for Research on Aging to support studies of longevity. The Buck Institute houses 21 independent laboratories that explore ways to lengthen the healthy lifespan of people; what it calls “healthspan.”

The institute advocates merging research on age-related diseases with continuing studies on human chronic disease.

Integrated approach

“What has come out of our work is a keen understanding that the factors driving aging are highly intertwined, and that in order to extend healthspan we need an integrated approach to health and disease with the understanding that biological systems change with age,” said Brian Kennedy, chief executive of the Buck Institute.

In a separate effort, Joon Yun, the president of health care investment firm Palo Alto Investors, is sponsoring a $1 million Palo Alto Longevity Prize, which will reward scientists who can resolve especially tricky challenges of aging in research animals.

Genomics guru Craig Venter and innovation specialist Peter Diamandis founded Human Longevity Inc., a company using genome data and analytics to fight the diseases that shorten and degrade human life.

And venture capitalist Peter Thiel began funding longevity research nearly a decade ago.

His Thiel Foundation backs the SENS Research Foundation, which is headed by Aubrey de Grey, one of the early scientists to say life spans of 120 or more years could be right around the corner.


What do you think?

View comments

Recommended for you

Featured video


What's behind the TCA, ETrade deal?

Deputy editor Bob Hordt talks with senior columnist Jeff Benjamin about what each party in the recent acquisition stands to gain by joining forces.

Latest news & opinion

What's in a name? For TCA by ETrade, everything

Trust Company of America is gone, and there's big buzz over the name change. But turning the custodian into an industry powerhouse will take a lot longer — if it happens at all.

When it comes to regulating AI in financial services, murky waters are ahead

Laws are unclear on how the technology fits in with compliance.

As Ameriprise case shows, firms on hook when brokers go bad ​

The SEC will collect $4.5 million from the brokerage firm for failing to supervise brokers who were ripping off clients.

10 highest paid professions in America today

These are the top-paying jobs in the U.S., according to Glassdoor.

Ameriprise to pay $4.5 million to settle SEC charges that five reps stole more than $1 million from clients

Agency censures firm for not protecting clients from thieving brokers.


Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting It'll help us continue to serve you.

Yes, show me how to whitelist

Ad blocker detected. Please whitelist us or give premium a try.


Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print